We are live on ! Find out more
MLAB icon

Mesa Laboratories

125 hedge funds and large institutions have $864M invested in Mesa Laboratories in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 40 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more capital invested

Capital invested by funds: $656M → $864M (+$208M)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

25% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 20

18% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 40

17.14% more ownership

Funds ownership: 73.56%90.7% (+17%)

2% more funds holding

Funds holding: 123125 (+2)

Holders
125
Holders Change
+2
Holders Change %
+1.63%
% of All Funds
2.72%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
25
Increased
47
Reduced
40
Closed
20
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Swiss National Bank
51
Swiss National Bank
Switzerland
$1.59M +$46.6K +200 +3%
Legal & General Group
52
Legal & General Group
United Kingdom
$1.58M +$1.35M +5,809 +857%
CIC
53
Crawford Investment Counsel
Georgia
$1.51M -$1.49M -6,400 -51%
UBS Group
54
UBS Group
Switzerland
$1.5M +$278K +1,193 +24%
Stifel Financial
55
Stifel Financial
Missouri
$1.4M -$26.3K -113 -2%
ASRS
56
Arizona State Retirement System
Arizona
$1.34M +$1.28M +5,500 New
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$1.28M +$24K +103 +2%
YMRC
58
Yorktown Management & Research Company
Virginia
$1.22M +$196K +843 +20%
WG
59
Winton Group
United Kingdom
$1.04M +$994K +4,270 New
Morgan Stanley
60
Morgan Stanley
New York
$1.02M -$3.59M -15,402 -79%
Barclays
61
Barclays
United Kingdom
$968K +$394K +1,693 +75%
Deutsche Bank
62
Deutsche Bank
Germany
$961K -$512K -2,197 -36%
Envestnet Asset Management
63
Envestnet Asset Management
Illinois
$807K -$61.5K -264 -7%
SO
64
STRS Ohio
Ohio
$733K +$699K +3,000 New
Tudor Investment Corp
65
Tudor Investment Corp
Connecticut
$716K +$682K +2,930 New
CS
66
Credit Suisse
Switzerland
$664K -$1.34M -5,748 -68%
Citigroup
67
Citigroup
New York
$654K +$417K +1,791 +201%
AIG
68
American International Group
New York
$629K +$100K +430 +20%
AQR Capital Management
69
AQR Capital Management
Connecticut
$615K +$67.8K +291 +13%
ACI
70
Alpha Cubed Investments
California
$592K
Prudential Financial
71
Prudential Financial
New Jersey
$570K +$310K +1,330 +133%
First Trust Advisors
72
First Trust Advisors
Illinois
$539K -$58.9K -253 -10%
Cambridge Investment Research Advisors
73
Cambridge Investment Research Advisors
Iowa
$518K +$21.7K +93 +5%
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$516K -$17.9K -77 -4%
OSAM
75
O'Shaughnessy Asset Management
Connecticut
$509K +$445K +1,911 +1,074%

MLAB Hedge Fund Activity: Q2 2019 in Review

125 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q2 2019, worth a combined $864M — up 32% from $656M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new MLAB positions and 20 closed out — a net gain of 5 holders — while 47 added to existing stakes and 40 trimmed.

The largest buyer was BlackRock, adding an estimated $83.2M. The largest seller was Massachusetts Financial Services, cutting an estimated $4.5M.

  • 125 institutional investors held Mesa Laboratories (MLAB) as of Q2 2019, up from 123 in Q1 2019.
  • Funds reported $864M of Mesa Laboratories stock for Q2 2019, up 32% quarter-over-quarter.
  • 25 funds opened new Mesa Laboratories positions in Q2 2019 and 20 closed out, a net change of +5 holders.
  • The largest Mesa Laboratories buyer in Q2 2019 was BlackRock, an estimated $83.2M added.
  • The largest Mesa Laboratories seller in Q2 2019 was Massachusetts Financial Services, an estimated $4.5M sold.

Based on aggregated 13F filings for Q2 2019.